NEWS
![]() Isomorphic Labs Raises $7.1 Billion in Funding in Six MonthsThe company founded by Demis Hassabis aims to accelerate AI-based drug design with this funding, even though it has not yet entered clinical trials. The investment was led by Greenoaks and Sequoia Capital, with participation from Alphabet and other investors. This is a news summary compiled for the AiPulse newsletter — not the original article. The original article is at aitimes.com. Read the original article AI Critique → English (automatic translation) |
